rs530700201

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_001170629.2(CHD8):​c.338C>T​(p.Ser113Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000399 in 1,555,372 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S113W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000038 ( 0 hom. )

Consequence

CHD8
NM_001170629.2 missense

Scores

4
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 2.36

Publications

1 publications found
Variant links:
Genes affected
CHD8 (HGNC:20153): (chromodomain helicase DNA binding protein 8) This gene encodes a member of the chromodomain-helicase-DNA binding protein family, which is characterized by a SNF2-like domain and two chromatin organization modifier domains. The encoded protein also contains brahma and kismet domains, which are common to the subfamily of chromodomain-helicase-DNA binding proteins to which this protein belongs. This gene has been shown to function in several processes that include transcriptional regulation, epigenetic remodeling, promotion of cell proliferation, and regulation of RNA synthesis. Allelic variants of this gene are associated with autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2016]
CHD8 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autism
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • intellectual developmental disorder with autism and macrocephaly
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • congenital myasthenic syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001170629.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.06866288).
BP6
Variant 14-21431306-G-A is Benign according to our data. Variant chr14-21431306-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 521546.
BS2
High AC in GnomAd4 at 8 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001170629.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHD8
NM_001170629.2
MANE Select
c.338C>Tp.Ser113Leu
missense
Exon 2 of 38NP_001164100.1Q9HCK8-1
CHD8
NM_020920.4
c.6+505C>T
intron
N/ANP_065971.2Q9HCK8-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHD8
ENST00000646647.2
MANE Select
c.338C>Tp.Ser113Leu
missense
Exon 2 of 38ENSP00000495240.1Q9HCK8-1
CHD8
ENST00000430710.8
TSL:1
c.6+505C>T
intron
N/AENSP00000406288.3Q9HCK8-2
CHD8
ENST00000557364.6
TSL:5
c.338C>Tp.Ser113Leu
missense
Exon 2 of 38ENSP00000451601.1Q9HCK8-1

Frequencies

GnomAD3 genomes
AF:
0.0000526
AC:
8
AN:
152200
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000377
AC:
6
AN:
159234
AF XY:
0.0000349
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000774
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000152
Gnomad NFE exome
AF:
0.0000146
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000385
AC:
54
AN:
1403054
Hom.:
0
Cov.:
32
AF XY:
0.0000375
AC XY:
26
AN XY:
694224
show subpopulations
African (AFR)
AF:
0.000185
AC:
6
AN:
32380
American (AMR)
AF:
0.000267
AC:
10
AN:
37410
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25310
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37036
South Asian (SAS)
AF:
0.0000495
AC:
4
AN:
80856
European-Finnish (FIN)
AF:
0.0000550
AC:
2
AN:
36340
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5722
European-Non Finnish (NFE)
AF:
0.0000275
AC:
30
AN:
1089312
Other (OTH)
AF:
0.0000341
AC:
2
AN:
58688
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000525
AC:
8
AN:
152318
Hom.:
0
Cov.:
32
AF XY:
0.0000403
AC XY:
3
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41566
American (AMR)
AF:
0.000131
AC:
2
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.531
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000416

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
not provided (3)
-
1
-
Complex neurodevelopmental disorder (1)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.17
T
Eigen
Benign
-0.12
Eigen_PC
Benign
-0.055
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.84
T
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.069
T
MetaSVM
Benign
-0.44
T
MutationAssessor
Benign
0.0
N
PhyloP100
2.4
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.19
Sift
Uncertain
0.029
D
Sift4G
Benign
0.20
T
PromoterAI
-0.011
Neutral
Varity_R
0.082
gMVP
0.13
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs530700201;
hg19: chr14-21899465;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.